Web Analytics

3 Latest Announced Rounds

$1,755.50M Raised in 55 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Tubulis GmbH

start up
Germany - Munich, Bayern
  • 16/10/2025
  • Series C
  • $359,197,300

Tubulis® generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. Our goal is to expand the therapeutic potential of antibody drug conjugates (ADCs) ushering in a new era and delivering better outcomes for patients. We will advance a range of conjugates, unlimited by indication, using our own discovery capabilities and by solving development challenges for partners with both antibody and chemical assets.


Related People